A Phase 1 Trial of Targeted Immunotherapy with Daratumumab Following Myeloablative Total Body Irradiation (TBI)-Based Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) in Children, Adolescents and Young Adults with High-Risk T-cell Acute Lymphoblastic Leukemia and Lymphoma (T-ALL/T-LLy) (ALLO-T-DART): A Ptctc-Facilitated Study

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Troy C. Quigg, Allyson M. Flower, David T. Teachey, Megan Lim, Yanling Liao, Lauren Harrison, Erin Morris, Stephan D. Voss, Rodney R. Miles, Xiaokui Mo, Adam B. Olshen, Alix Eden Seif
+1 more Mitchell Stuart Cairo
DOI: 10.1016/j.jtct.2025.12.885
Cited by: 0

Fields of Study & Subjects

Acute Lymphoblastic Leukemia research Hematopoietic Stem Cell Transplantation CAR-T cell therapy research

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S591–S592
Publication date
1 February 2026
Language
EN